HORIZON THERAPEUTICS PLC(NASDAQ:HZNP) stock News

HZNP Latest News, Press Relases and Analysis

All

Press Releases

a year ago - By: InvestorPlace - Mentions: AMGN CSIQ BLK DSX

3 Stocks to Buy Low Today With High Hopes for Tomorrow

2 years ago - By: Bloomberg - Mentions: AMGN

Amgen Expects a 2024 Sales Jump, Sets Sights on Obesity Market

2 years ago - By: Seeking Alpha - Mentions: PFE SGEN AMGN

Pfizer to close Seagen buyout this week as regulatory reviews complete (NYSE:PFE)

2 years ago - By: Seeking Alpha - Mentions: CME SGEN ABBV VRSK ...

Tudor Investment opens new Seagen, AbbVie bets; exits Immersion, Lennox (NASDAQ:CME)

2 years ago - By: Benzinga

Peering Into Horizon Therapeutics's Recent Short Interest

2 years ago - By: Benzinga

Here's How Much $100 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth Today

2 years ago - By: Bloomberg - Mentions: MSFT ATVI

Microsoft-Activision Takeover Emboldens Merger Arb Traders to Boost Their Bets

2 years ago - By: Bloomberg - Mentions: AMGN

Hedge Funds Won Big on Bets Amgen-Horizon Deal Would Go Through

2 years ago - By: Seeking Alpha - Mentions: AMGN

Amgen completes $27.8B acquisition of Horizon Therapeutics (NASDAQ:AMGN)

2 years ago - By: Horizon Therapeutics plc

Rule 17(e) Announcement - Horizon Therapeutics plc

2 years ago - By: Seeking Alpha - Mentions: AMGN

Amgen wins Irish approval for planned Horizon Therapeutics purchase

2 years ago - By: Horizon Therapeutics plc

Rule 17(d) Announcement – Horizon Therapeutics plc

2 years ago - By: Horizon Therapeutics plc

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

2 years ago - By: Seeking Alpha - Mentions: AMGN MS

Horizon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Amgen

2 years ago - By: Horizon Therapeutics plc

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

2 years ago - By: Horizon Therapeutics plc

Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023

2 years ago - By: Horizon Therapeutics plc

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

2 years ago - By: Horizon Therapeutics plc

New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes

2 years ago - By: Horizon Therapeutics plc

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

2 years ago - By: Horizon Therapeutics plc

Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry

2 years ago - By: Horizon Therapeutics plc

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

2 years ago - By: Horizon Therapeutics plc

Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List

2 years ago - By: Horizon Therapeutics plc

Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata

2 years ago - By: InvestorPlace - Mentions: MRNA AMGN PFE

The 3 Most Undervalued Biotech Stocks to Buy in September 2023

2 years ago - By: Seeking Alpha - Mentions: AMGN

Horizon Therapeutics stock ticks higher as Amgen end date extended until December

2 years ago - By: Horizon Therapeutics plc

Horizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement

2 years ago - By: Horizon Therapeutics plc

HORIZON THERAPEUTICS PLC (HZNP) Stock News

HZNP Latest News, Press Relases and Analysis

3 Stocks to Buy Low Today With High Hopes for Tomorrow

Amgen Expects a 2024 Sales Jump, Sets Sights on Obesity Market

Pfizer to close Seagen buyout this week as regulatory reviews complete (NYSE:PFE)

Tudor Investment opens new Seagen, AbbVie bets; exits Immersion, Lennox (NASDAQ:CME)

Peering Into Horizon Therapeutics's Recent Short Interest

Here's How Much $100 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth Today

Microsoft-Activision Takeover Emboldens Merger Arb Traders to Boost Their Bets

Hedge Funds Won Big on Bets Amgen-Horizon Deal Would Go Through

Amgen completes $27.8B acquisition of Horizon Therapeutics (NASDAQ:AMGN)

Rule 17(e) Announcement - Horizon Therapeutics plc

Amgen wins Irish approval for planned Horizon Therapeutics purchase

Rule 17(d) Announcement – Horizon Therapeutics plc

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

Horizon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Amgen

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List

Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata

The 3 Most Undervalued Biotech Stocks to Buy in September 2023

Horizon Therapeutics stock ticks higher as Amgen end date extended until December

Horizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement

Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement